Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarkko Rautio

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Current Topics in Medicinal Chemistry|June 16, 2011
Prodrugs - an efficient way to breach delivery and targeting barriersKristiina M Huttunen, Jarkko Rautio
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2011
[Prodrug technology in the development of medicinal agents]Lauri Peura, Kalle Malmioja, Jarkko Rautio
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 8, 2017
Prodrugs - Recent approvals and a glimpse of the pipelineJarkko Rautio, Jussi Kärkkäinen, Kenneth B Sloan
Advanced Drug Delivery Reviews|July 6, 2017
Prodrugs in medicinal chemistry and enzyme prodrug therapiesRaoul Walther, Jarkko Rautio, Alexander N Zelikin
Pharmacological Reviews|July 9, 2011
Prodrugs--from serendipity to rational designKristiina M Huttunen, Hannu Raunio, Jarkko Rautio
Pharmaceutical Research|November 17, 2006
Design for optimized topical delivery: Prodrugs and a paradigm changeKenneth B Sloan, Scott C Wasdo, Jarkko Rautio
Food Chemistry|February 15, 2025
Unraveled cancer cell survival-associated amino acid metabolism of HepG2 cells altered by Thai rat-tailed radish microgreen extract examined by untargeted LC-MS/MS analysisKarnchanok Kaimuangpak, Marko Lehtonen, Jarkko Rautio, et al.
The Journal of Pharmacy and Pharmacology|July 5, 2003
A novel D2-dopaminergic and alpha2-adrenoceptor receptor agonist induces substantial and prolonged IOP decrease in normotensive rabbitsJouko Savolainen, Jarkko Rautio, Roberta Razzetti, et al.
The AAPS Journal|May 1, 2008
Prodrug approaches for CNS deliveryJarkko Rautio, Krista Laine, Mikko Gynther, et al.
Molecules (Basel, Switzerland)|November 14, 2019
Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma CellsTarapong Srisongkram, Natthida Weerapreeyakul, Jussi Kärkkäinen, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Current Topics in Medicinal Chemistry|June 16, 2011
Prodrugs - an efficient way to breach delivery and targeting barriersKristiina M Huttunen, Jarkko Rautio
Duodecim; Laaketieteellinen Aikakauskirja|March 29, 2011
[Prodrug technology in the development of medicinal agents]Lauri Peura, Kalle Malmioja, Jarkko Rautio
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 8, 2017
Prodrugs - Recent approvals and a glimpse of the pipelineJarkko Rautio, Jussi Kärkkäinen, Kenneth B Sloan
Advanced Drug Delivery Reviews|July 6, 2017
Prodrugs in medicinal chemistry and enzyme prodrug therapiesRaoul Walther, Jarkko Rautio, Alexander N Zelikin
Pharmacological Reviews|July 9, 2011
Prodrugs--from serendipity to rational designKristiina M Huttunen, Hannu Raunio, Jarkko Rautio
Pharmaceutical Research|November 17, 2006
Design for optimized topical delivery: Prodrugs and a paradigm changeKenneth B Sloan, Scott C Wasdo, Jarkko Rautio
Food Chemistry|February 15, 2025
Unraveled cancer cell survival-associated amino acid metabolism of HepG2 cells altered by Thai rat-tailed radish microgreen extract examined by untargeted LC-MS/MS analysisKarnchanok Kaimuangpak, Marko Lehtonen, Jarkko Rautio, et al.
The Journal of Pharmacy and Pharmacology|July 5, 2003
A novel D2-dopaminergic and alpha2-adrenoceptor receptor agonist induces substantial and prolonged IOP decrease in normotensive rabbitsJouko Savolainen, Jarkko Rautio, Roberta Razzetti, et al.
The AAPS Journal|May 1, 2008
Prodrug approaches for CNS deliveryJarkko Rautio, Krista Laine, Mikko Gynther, et al.
Molecules (Basel, Switzerland)|November 14, 2019
Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma CellsTarapong Srisongkram, Natthida Weerapreeyakul, Jussi Kärkkäinen, et al.
Pageof 9